Cocaine abuse in methadone maintenance programs: integrating pharmacotherapy with psychosocial interventions

Journal of Psychoactive Drugs
S K AvantsT R Kosten


Cocaine abuse by methadone-maintained patients threatens to undermine the success of methadone programs by sustaining a drug-abusing lifestyle as well as contributing to the spread of HIV. The search for a pharmacotherapeutic agent for the treatment of cocaine has met with limited success. The most promising results emerge when specific agents, such as desipramine, are matched appropriately to specific patient characteristics, such as depression or antisocial personality disorder. For some patients, abstinence from cocaine may also require the addition of intensive psychosocial treatments that target the considerable problems faced by inner-city opioid-addicted individuals. This article discusses ways in which future research could be directed toward investigating the interaction between psychosocial services and pharmacologic treatments, while at the same time developing and testing hypotheses concerning appropriate patient-treatment matching variables.


Apr 28, 1977·The New England Journal of Medicine·N E Zinberg
Oct 1, 1992·Drug and Alcohol Dependence·A I AltermanC P O'Brien
Jan 1, 1992·Journal of Substance Abuse Treatment·T Chiavaroli
Jun 28, 1992·Annals of the New York Academy of Sciences·D Beitner-JohnsonE J Nestler
Sep 1, 1992·Hospital & Community Psychiatry·A I AltermanA T McLellan
Nov 1, 1992·Archives of General Psychiatry·I O ArndtC P O'Brien
Nov 1, 1992·Archives of General Psychiatry·T R KostenR S Schottenfeld
Nov 1, 1992·Archives of General Psychiatry·R E Meyer
Nov 1, 1992·Archives of General Psychiatry·L E HollisterH Gillespie
Nov 1, 1992·British Journal of Addiction·H R Kranzler, L O Bauer
Jun 1, 1992·Biological Psychiatry·J P SeibylD S Charney
Sep 1, 1991·American Journal of Public Health·S R YancovitzJ W Robinson
Jan 1, 1991·Journal of Substance Abuse Treatment·W S CondelliJ V Rachal
Jan 1, 1991·Journal of Substance Abuse·G W JoeR L Hubbard
Jan 1, 1991·Archives of General Psychiatry·A MargolinT Kosten
Sep 1, 1991·The American Journal of Drug and Alcohol Abuse·K M CarrollD S Keller
Aug 1, 1990·The International Journal of the Addictions·W W Weddington
Jan 1, 1991·British Journal of Addiction·D A Curson
May 1, 1991·The American Journal of Psychiatry·D MetzgerJ J Platt
Feb 1, 1991·European Journal of Orthodontics·J V Ball, N P Hunt
Jan 1, 1991·The International Journal of the Addictions·G W JoeR L Hubbard
Apr 1, 1990·The Journal of Nervous and Mental Disease·T R Kosten
Jan 1, 1990·Journal of Substance Abuse Treatment·D Nolimal, T J Crowley
Feb 1, 1989·Archives of General Psychiatry·F H GawinC Morgan
Feb 4, 1989·Lancet·P BergerT R Kosten
Sep 1, 1989·Journal of Studies on Alcohol·D J RohsenowD B Abrams
May 18, 1985·Lancet·C A Dackis, M S Gold
May 1, 1988·Journal of Abnormal Psychology·R E Vuchinich, J A Tucker
Mar 1, 1988·The Journal of Nervous and Mental Disease·T R KostenH D Kleber
Jan 1, 1988·Addictive Behaviors·A C Ogborne, H M Annis
Jan 1, 1988·Addictive Behaviors·D G Schlundt, R T Zimering
Jan 1, 1986·Advances in Alcohol & Substance Abuse·D HuntD Strug
Jan 1, 1987·Journal of Substance Abuse Treatment·D A Calsyn, A J Saxon
Jan 1, 1986·The American Journal of Drug and Alcohol Abuse·T R KostenH D Kleber
Mar 1, 1987·Archives of General Psychiatry·T R KostenH D Kleber
Jun 1, 1985·The International Journal of the Addictions·E C Senay
Jan 1, 1985·Journal of Substance Abuse Treatment·R W Conroy
Aug 1, 1985·The International Journal of the Addictions·D L StrugB Spunt
Jun 1, 1983·Archives of General Psychiatry·B J RounsavilleH D Kleber
Oct 1, 1983·The Journal of Nervous and Mental Disease·A T McLellanK A Druley

❮ Previous
Next ❯


Jun 8, 2002·Sozial- Und Präventivmedizin·Richard BlättlerAmbros Uchtenhagen
Nov 1, 1996·Journal of Substance Abuse Treatment·A RosenblumB Stimmel
Apr 16, 2002·Journal of Consulting and Clinical Psychology·Nancy M Petry, Bonnie Martin
Aug 20, 2003·Journal of Psychoactive Drugs·Evan Kletter
Jan 5, 2002·Journal of Clinical Psychopharmacology·P HruzE Seifritz
Oct 22, 1998·Substance Use & Misuse·S MaguraS Demsky

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.